Connect with us

Technology

Lindus Health and Aktiia to launch observational clinical trial for Aktiia’s Optical Blood Pressure Monitoring Device

Published

on

NEW YORK, July 9, 2024 /PRNewswire/ — Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, and Aktiia, the pioneering blood pressure intelligence startup offering non-invasive and cuffless continuous blood pressure monitoring, have announced the launch of their clinical trial to evaluate user satisfaction with Aktiia’s optical blood pressure monitoring (OBPM) device in hypertensive individuals.

Hypertension, or high blood pressure, is estimated to affect over 1.3 billion adults globally, and is the leading cause of heart disease, stroke, kidney disease, and many other diseases. Devices that continuously monitor blood pressure can offer valuable insights into hypertension severity, treatment efficacy, and fluctuations related to daily activity, lifestyle, and sleep patterns.

This study will examine user experience with Aktiia’s non-invasive, cuffless OPBM device. The device, worn as a bracelet, measures blood pressure continuously using optical sensors, offering a more convenient alternative to traditional blood pressure cuffs. In addition to measuring satisfaction with the device, the trial will also observe the evolution of participants’ blood pressure over the study period and correlate this data with sociodemographic, lifestyle, and health factors.

Lindus Health and Aktiia will enroll 7,500 participants with known hypertension in this 12-week clinical trial. Lindus Health will provide end-to-end study management, including protocol development, regulatory submissions, recruitment, monitoring, and data management. They will utilize their in-house virtual site and digital marketing capabilities for patient recruitment through digital advertising as well as primary care screening and patient community outreach. A dedicated study website will be developed with relevant trial information and integrated with Lindus Health’s proprietary eClinical platform, Citrus™, to enable candidates to seamlessly complete pre-screening and eConsent.

“Lindus Health is incredibly humbled to be collaborating on the Aktiia trial, where we’ll have the ability to provide thousands of individuals with continuous visibility on their blood pressure on a continuous basis,” said Michael Young, co-founder at Lindus Health. “Hypertension greatly burdens both patients and healthcare systems and there is an evident need for technologies that effectively help individuals manage chronic diseases while seamlessly integrating with their everyday lives.”

“Aktiia’s technology gives individuals greater autonomy to better manage their health,” said Dr. Jay Shah, Chief Medical Officer at Aktiia. “Our device and smartphone application allow patients and providers to understand their blood pressure patterns and changes in real-time, making it easier to pinpoint causes for fluctuations. We’re excited and proud to be working with Lindus Health to deliver blood pressure intelligence to patients with hypertension to help them better manage their condition.”

Favorable outcomes pertaining to user experience will underscore the value in developing wearable devices to continuously monitor, manage, and prevent chronic diseases that are both accurate and comfortable.

About Lindus Health

Lindus Health is an anti-CRO running radically faster and more reliable trials for life science pioneers – bringing ground-breaking treatments to patients more quickly. This is achieved through a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), a world-class clinical operations team with its unique software platform, and access to over 30 million Electronic Health Records.

Clinical trials are the biggest bottleneck to advances in healthcare. Lindus Health removes this constraint by handling the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management.

To date, Lindus Health has delivered more than 90 trials across the US, UK and Europe to tackle a range of conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia. The company has raised over $24M from investors including Peter Thiel, CREANDUM, Firstminute Capital, Presight Capital, Seedcamp, Hambro Perks, Amino Collective and Calm/Storm.

About Aktiia

Founded in Switzerland in May 2018, Aktiia was created out of a passion to develop the best
products for diagnosing and treating hypertension. Founders Drs. Mattia Bertschi (CEO) and Josep Solà (CTO) spent 15 years at the prestigious Swiss research institute CSEM, deciphering the language of the heart and blood vessels to deepen our understanding of blood pressure – the world’s most common risk factor of death and disease.

Today, Aktiia’s diverse team of over 50 extraordinary individuals is transforming years of innovative research into a global healthcare solution, offering the most complete and intuitive blood pressure monitoring and management tools on the market.

https://aktiia.com
Media contact: press@aktiia.com

Lindus Health Media Contact:
Jodi Perkins
Amendola for Lindus Health
jperkins@acmarketingpr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lindus-health-and-aktiia-to-launch-observational-clinical-trial-for-aktiias-optical-blood-pressure-monitoring-device-302191705.html

SOURCE Lindus Health

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Evermos Partners with the International Labour Organisation (ILO) to Deliver Entrepreneurship Training for Indonesia’s Vulnerable Groups

Published

on

By

BANDUNG, Indonesia, June 19, 2026 /PRNewswire/ — Evermos, a Bandung-based reseller platform focused on MSME empowerment, sees significant potential for vulnerable groups to achieve economic empowerment through digital business. According to Statistics Indonesia (BPS), the labour force participation rate among persons with disabilities stood at only around 20% in early 2025, far behind the roughly 70% recorded among people without disabilities.

“We see digital business as a bridge to lower the barriers to economic access for persons with disabilities and returning migrant workers. No significant capital, no need for a physical location, a mobile phone is enough. This business model opens up the opportunity for them to build an independent and sustainable source of income.”
Iqbal Muslimin, Chief of Sustainability, Evermos

The collaboration runs under the ILO project Promise II Impact, which aims to improve MSMEs’ access to financial services and has been running since 2023. It aligns with Evermos’ vision of advancing MSME empowerment across Indonesia. Evermos provides the digital business ecosystem, from its reseller platform and curated halal products to business training and mentoring, while the ILO brings a decent work framework and financial literacy modules that help participants start digital businesses on sound financial footing.

Since 2023, more than 230 beneficiaries have felt the project’s impact across various cities. In March 2026, Evermos and the ILO, together with the Migrant Worker Resource Centre (MRC), delivered digital entrepreneurship training for migrant workers in Cirebon, West Java. A similar programme was also held in the Special Region of Yogyakarta, involving persons with disabilities from various groups, including those supported by the BPKK of the Indonesian Ministry of Manpower, the Indonesian Association of Women with Disabilities (HWDI) Sleman, and the Mitra Sejahtera Disability Empowerment Centre (PPDMS) Gunungkidul.

During the training, participants were guided to try selecting products to sell directly through the Evermos app, to apply digital marketing techniques, and to strengthen their entrepreneurial mindset so that earnings from their working years can grow into long-term productive assets. They were also introduced to and practised using WhatsApp Business as one tool to start a digital business. Meanwhile, the ILO team complemented the training with basic financial literacy so participants could manage their new businesses soundly.

“For us, digital transformation also becomes meaningful when it reaches vulnerable groups, those furthest from the information they need to empower themselves economically. Through Evermos, a person with a disability or a migrant worker returning to their hometown can start a business with nothing more than a smartphone, without significant capital — and that is what truly inclusive empowerment looks like.”
Arip Tirta, President, Evermos

“The conclusion of this series of activities is not the end of the participants’ journey, but the beginning of their path as digital entrepreneurs. Three years of experience have shown that when vulnerable groups gain access to the right skills, technology, and mentoring, they are able to create economic opportunities for themselves. The partnership between the ILO and Evermos is an example of how collaboration can help bring about more inclusive economic growth that leaves no one behind.”
Djauhari Sitorus, Project Manager, Promise II Impact

Closing out three years of the Promise II Impact project, Evermos and the ILO hope this contribution can encourage vulnerable groups to take part in driving Indonesia’s economic growth as digital entrepreneurs. By opening access to doing business digitally, vulnerable groups can become economically empowered and self-reliant. Beyond that, the collaboration is intended to serve as a model of inclusive empowerment that can be replicated across more regions — so that an economy open to all is not merely an aspiration, but something that can be realised.

About Evermos

Evermos is a reseller platform that integrates a distribution network, commerce services, and a curated range of halal products with business communities focused on serving underserved communities. Evermos supports the success of its resellers regardless of gender, educational background, or geographic location by providing regular business training and mentoring.

Founded in November 2018, Evermos has built the largest reseller-based connected commerce network in Indonesia, with over 1 million resellers nationwide, more than 200,000 active monthly sellers, and hundreds of products from Indonesian MSMEs. Evermos has also received various prestigious accolades, including the Top CSR Award – Star 4 2026, the Seal Business Sustainability Award 2025, the Nikkei Asia Award 2023, and the UN Women 2024 Indonesian Women’s Empowerment Principles (WEPs), and is a member of the global Endeavor Entrepreneur network. Evermos is also part of the World Economic Forum’s Global Innovators Community.

View original content to download multimedia:https://www.prnewswire.com/news-releases/evermos-partners-with-the-international-labour-organisation-ilo-to-deliver-entrepreneurship-training-for-indonesias-vulnerable-groups-302805209.html

SOURCE Evermos

Continue Reading

Technology

Innovid by Mediaocean Positioned as a Leader in the SPARK Matrix™: AdTech Platform, 2026 by QKS Group

Published

on

By

PUNE, India, June 19, 2026 /PRNewswire/ — QKS Group announced today that it has named Innovid by Mediaocean as a leader in the SPARK Matrix™: AdTech Platform, 2026. This comprehensive evaluation provides a detailed competitive analysis, market ranking, and strategic insights to help users evaluate global vendor capabilities and market positions.

This recognition also reflects Innovid’s continued investment in AI-powered execution and the value it is delivering to customers and the industry at large. Earlier this month, the company introduced NIVO, its AI core for agents and orchestration, helping marketers turn intelligence into action across the advertising lifecycle. Early adopters have already reported workflow efficiency gains of up to 90%. 

“Innovid by Mediaocean’s leadership position in the advertising technology market is supported by its breadth across creative management, ad serving, campaign execution, measurement, optimization, and workflow automation,” said Richa Choubey, Senior Analyst, QKS Group. “The platform is particularly strong in helping advertisers manage campaigns across connected TV, digital, social, and linear media while providing greater consistency in execution and measurement across channels. Through cross-channel delivery capabilities, independent measurement, AI-enabled optimization, and interoperability across the advertising ecosystem, Innovid by Mediaocean enables brands and agencies to improve operational efficiency, strengthen performance visibility, and better manage increasingly fragmented media environments. Its integrated approach supports organizations seeking greater control over campaign operations, measurement consistency, and linkage between advertising investments and business outcomes.”

Analyst Assessment: Aligning with Market Dynamics

Innovid operates at the intersection of several of the most significant trends shaping the advertising technology landscape, including the rise of CTV, the growing demand for independent measurement, increasing media fragmentation, and the application of AI to campaign execution and optimization. Rather than competing solely on individual point capabilities, the platform’s value proposition lies in its ability to connect creative management, ad serving, measurement, and optimization workflows across channels that have traditionally been managed in silos.

As advertisers navigate an increasingly complex ecosystem characterized by evolving privacy requirements, proliferating media environments, and heightened expectations for accountability, platforms that can provide consistency, interoperability, and operational efficiency become increasingly important. Innovid’s continued investments in cross-channel measurement, CTV innovation, and AI-enabled workflow automation reflect a clear understanding of these market dynamics. While the AdTech market remains highly competitive and rapidly evolving, Innovid has established itself as a significant independent player with a differentiated position in helping brands, agencies, and media organizations execute, measure, and optimize campaigns across fragmented digital and television environments. Its ability to balance scale, openness, and innovation positions it well as organizations seek greater transparency and control over advertising performance in an omnichannel world.

“Innovid demonstrates differentiated capabilities in creative management and optimization, leveraging AI and automation to improve campaign efficiency and effectiveness,” said Umang Thakur, Vice President and Principal Analyst, QKS Group. “Its support for omnichannel activation, unified measurement, and cross-platform creative governance makes it well suited for organizations seeking to centralize advertising operations and maximize the impact of creative assets at scale.”

Building on a Foundation of AI Innovation

In 2025, QKS Group named Innovid the ‘Most Valuable Pioneer‘ in its AI Maturity Matrix for AdTech, highlighting the company’s ability to embed intelligence across the campaign lifecycle. With the launch of NIVO AI, Innovid has evolved that embedded intelligence into live, scalable execution, addressing the multi-channel complexities and fragmentation challenges highlighted in the QKS report.

“What stands out in this report is the growing need for greater connectivity across the advertising ecosystem,” said Grant Parker, President, Innovid. “Marketers aren’t struggling with a lack of tools; they’re struggling with disconnected workflows, fragmented data, and operational complexity. With NIVO, we’re helping brands and agencies bring those workflows together, turning signals into coordinated action across creative, delivery, measurement, and optimization.”

Access the Report

To download the full report and explore the visit SPARK Matrix™: AdTech Platform, 2026.

About Innovid

Innovid is the leading omnichannel advertising platform, empowering marketers to create, deliver, measure, and optimize ad-supported experiences. At the core of Innovid is NIVO, powering AI agents and orchestration to activate, adapt, and optimize campaigns across the advertising lifecycle. As part of Mediaocean, Innovid is tied into Prisma, the industry’s core ad infrastructure for planning, buying, and billing, as well as Protected for verification, fraud detection, and brand safety. Visit www.innovid.com to learn more.

Media Contact:
Megan Coyle
Megan@innovid.com

About QKS Group

QKS Group is a global analyst and advisory firm helping enterprises, technology vendors, and investors make trusted, data-driven decisions. Our portfolio spans the flagship SPARK Matrix™ evaluation framework, SPARK Plus™ analyst advisory platform, QKS Intelligence™ for market and competitive tracking, and QKS Community™ for CXO leaders and practitioners. All offerings are powered by a Human-Intelligence-driven framework and QKS’s closed-loop research methodology–integrating expert-led insights, quantitative modeling, and continuous validation to deliver credible, outcome-focused intelligence. For more available research, please visit Research.

Media Contact:
Anish
PR & Media Relations
QKS Group 
5th Floor, Wing 2, Cluster C, 
EON Free Zone, Kharadi,
Pune, India
Email: support@qksgroup.com
Content Source: https://qksgroup.com/newsroom/innovid-by-mediaocean-positioned-as-a-leader-in-the-spark-matrix-adtech-platform-2026-by-qks-group-1699 
Connect with us on LinkedIn- https://www.linkedin.com/company/qksgroup/

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/innovid-by-mediaocean-positioned-as-a-leader-in-the-spark-matrix-adtech-platform-2026-by-qks-group-302805199.html

Continue Reading

Technology

Innoscience’s current products are not affected by both rulings of the Munich Regional Court

Published

on

By

MUNICH, June 18, 2026 /PRNewswire/ — Innoscience today announced that the Munich Regional Court has just issued a pair of rulings, from which it could be confirmed that Innoscience’s currently marketed gallium nitride (“GaN”) power device products fall outside the scope of Infineon’s asserted German patents and may be commercialized in Germany without restriction.

These rulings are fully consistent with the final determination issued last month by the U.S. International Trade Commission (“ITC”), which found that Innoscience’s current products do not infringe Infineon’s asserted U.S. patent relating to packaging design (U.S. Patent No. 9,899,481). The Munich case concerns the German counterparts of that same patent family. In line with the ITC’s findings, the Munich Court found infringement only with respect to a limited set of legacy products—certain packaged 650–700V transistors—that had already been discontinued. Therefore, any injunction granted would not apply to Innoscience’s current product portfolio. As a result, there is no impact on Innoscience’s ongoing operations or its customers’ use of its products in Germany.

The decisions mark another significant milestone in Innoscience’s string of favorable outcomes across major jurisdictions. They follow the company’s recent success in China, where it secured an injunction and damages award against Infineon, as well as its decisive victory at the ITC in the United States last month. Together, these rulings reaffirm the legality of Innoscience’s current product portfolio and its ability to operate freely in key global markets.

While proceedings in Germany remain ongoing, including Innoscience’s invalidity challenges to the asserted German patent, the growing body of decisions across China, the United States, and Germany underscores that the global litigation campaign initiated by Infineon has not altered the competitive position of Innoscience’s core products. To the contrary, independent judicial findings across multiple jurisdictions have consistently validated the robustness of Innoscience’s technology and reinforced market confidence in the company’s product compliance and innovation capabilities.

Innoscience remains committed to advancing its technology leadership and expanding its global footprint, delivering cutting-edge GaN solutions to customers worldwide in a fair and competitive marketplace.

View original content:https://www.prnewswire.com/news-releases/innosciences-current-products-are-not-affected-by-both-rulings-of-the-munich-regional-court-302805093.html

SOURCE InnoScience

Continue Reading

Trending